CRH plc (CRH)

Revenue growth above 1.5x VMC's 8.23%. David Dodd would confirm if the firm has a unique advantage driving sales higher.

Gross profit growth above 1.5x VMC's 24.43%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.

EBIT growth above 1.5x VMC's 34.86%. David Dodd would confirm if core operations or niche positioning yield superior profitability.

Operating income growth above 1.5x VMC's 34.86%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.

Net income growth above 1.5x VMC's 76.98%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.

EPS growth above 1.5x VMC's 76.36%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.

Diluted EPS growth above 1.5x VMC's 74.55%. David Dodd would see if there's a robust moat protecting these shareholder gains.

Share reduction while VMC is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.

Reduced diluted shares while VMC is at 0.23%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.

10Y revenue/share CAGR above 1.5x VMC's 172.59%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.

5Y revenue/share CAGR above 1.5x VMC's 61.53%. David Dodd would look for consistent product or market expansions fueling outperformance.

3Y revenue/share CAGR above 1.5x VMC's 21.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.

Net income/share CAGR above 1.5x VMC's 194.97% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.

5Y net income/share CAGR above 1.5x VMC's 9.37%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.

3Y net income/share CAGR above 1.5x VMC's 14.61%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

We cut SG&A while VMC invests at 5.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.